Where does obsessive-compulsive disorder belong in DSM-V?

Depression and Anxiety

Volumn 25, Issue 4, 2008, Pages 336-347

  Storch, Eric A ^a   Abramowitz, Jonathan ^b   Goodman, Wayne K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Diagnostic and Statistical Manual for Mental Disorders; Impulse control disorders; Obsessive compulsive disorder; Obsessive compulsive spectrum; Tourette's syndrome

Indexed keywords

NEUROTRANSMITTER;

CLINICAL FEATURE; COMORBIDITY; CONFERENCE PAPER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; FAMILY HISTORY; HUMAN; NEUROBIOLOGY; OBSESSIVE COMPULSIVE DISORDER; PHENOMENOLOGY; PHENOTYPE; PRIORITY JOURNAL; TREATMENT RESPONSE; ANXIETY DISORDERS; COMPULSIVE PERSONALITY DISORDER; OBSESSIVE-COMPULSIVE DISORDER;

ANXIETY DISORDERS; COMPULSIVE PERSONALITY DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; NEUROBIOLOGY; OBSESSIVE-COMPULSIVE DISORDER;

EID: 42949117737     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20488     Document Type: Conference Paper

References (92)

1. Abramowitz JS. 2005. Hypochondriasis: conceptualization, treatment, and relationship to obsessive-compulsive disorder. Ann Clin Psychiatry 17:211-217.
2. Abramowitz JS, Braddock AE. 2006. Hypochondriasis: conceptualization, treatment, and relationship to obsessive-compulsive disorder. Psychiatr Clin North Am 29:503-519.
3. Abramowitz JS, Houts AC. 2002. What is OCD and what is not? problems with the OCD spectrum concept. The Scientific Review of Mental Health Practice 1:139-156.
4. Abramowitz JS, Houts AC. 2005. Concepts and controversies in obsessive-compulsive disorder. New York, NY, USA: Springer Science. 437 p.
5. Abramowitz JS, Tolin DF, Street GP. 2001. Paradoxical effects of thought suppression: a meta-analysis of controlled studies. Clin Psychol Rev 21:683-703.
6. Abramowitz J, Whiteside SP, Deacon BJ. 2005. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Ther 36:55-63.
7. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
8. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: American Psychiatric Association.
9. Amir N, Foa E, Coles M. 1997. Factor structure of the Yale-Brown Obsessive Compulsive Scale. Psychol Assess 9:312-316.
10. Barlow DH. 2002. Anxiety and its disorders: the nature and treatment of anxiety and panic (2nd ed.). New York, NY, USA: Guilford Press.
11. Barrett P, Healy L. 2003. An examination of the cognitive processes involved in childhood obsessive-compulsive disorder. Behav Res Ther 41:285-299.
12. Barsky AJ, Wyshak G, Klerman GL. 1992. Psychiatric comorbidity in DSAI-III-R hypochondriasis. Arch Gen Psychiatry 49:101-108.
13. Bartz JA, Hollander E 2006. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychophannacol Biol Psychiatry 30:338-352.
14. Beck AT, Emery G. 1985. Anxiety disorders and phobias: a cognitive perspective. New York: Basic Books.
15. Barsky AJ, Wyshak G, Klerman GL. 1992. Psychiatric comorbidity in DSM-III-R hypochondriasis. Arch Gen Psychiatry 49:101-108.
16. Batrz JA, Hollander E. 2006. Is obsessive-compulsive disorder an anxiety disorder? Prog Neuropsychopharmacol Biol Psychiatry 30:338-352.
17. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BA, Grados MA, Nestadt G. 2000. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 48:287-293.
18. Boyer W. 1995. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 10:45-49.
19. Christenson GA, Mackenzie TB, Mitchell JF, Callies AL. 1991. A placebo controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry 148:1566-1571.
20. Clark DM. 1986. A cognitive approach to panic. Behav Res Ther 24:461-470.
21. Clark DM. 1999. Anxiety disorders: why they persist and how to treat them. Behav Res Ther 37:S5-S27.
22. Clark DM, Wells A. 1995. A cognitive model of social phobia. In: Heimberg R, Liebowitz M, Hope DA, Schneier FR, editors. Social phobia: diagnosis, assessment and treatment New York: Guilford Press. p 69-93.
23. Clark DM, Ehlers A, Hackmann A, McManus F, Fennell M, Grey N, Waddington L, Wild J. 2006. Cognitive therapy versus exposure and applied relaxation in social phobia: a randomized controlled trial. J Consult Clin Psychol 74:568-578.
24. Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B. 2003. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psychol 71:1058-1067.
25. Deacon BJ, Abramowitz JS. 2005. The Yale-Brown obsessive compulsive scale: factor analysis, construct validity, and suggestions for refinement. J Anxiety Disord 19:573-585.
26. Deacon B, Abramowitz J. 2006. Anxiety sensitivity and its dimensions across the anxiety disorders. J Anxiety Disord 20:837-857.
27. Degnan KA, Fox NA. 2007. Behavioral inhibition and anxiety disorders: multiple levels of a resilience process. Dev Psychopathol 19:729-746.
28. de Silva P, Menzies RG, Shafran R. 2003. Spontaneous decay of compulsive urges: the case of covert compulsions. Behav Res Ther 41:129-137.
29. DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell D, Fontaine R. Greist JH, Reichler R, Katz R, Landau P. 1992. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial. J Am Acad Child Adolesc Psychiatry 31:45-49.
30. Dougherty DD, Loh R, Jenike MA, Keuthen NJ. 2006. Single modality versus dual modality treatment for trichorillomania: sertraline, behavioral therapy, or both? J Clin Psychiatry 67:1086-1092.
31. Foa EB, Kozak MJ. 1995. DSM-IV field trial: obsessive-compulsive disorder. Am J Psychiatry 152:90-96.
32. Foa EB, Rothbaum BO. 1998. Treating the trauma of rape: Cognitive-behavioral therapy for PTSD. New York, NY, USA: Guilford Press.
33. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X. 2005. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive compulsive disorder. Am J Psychiatry 162:151-161.
34. Freeston MH, Ladouceur R. 1997. What do patients do with their obsessive thoughts? Behav Res Ther 35:335-348.
35. Geller DA, Biederman J, Stewart SE, Mullin B, Martin A, Spencer T, Faraone SV. 2003. Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. Am J Psychiatrv 160:1919-1928.
36. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. 1989. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Arch Gen Psychiatry 46:36-14.
37. Grant JE, Potenza MN. 2004. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry 16:27-34.
38. Greist J, Chouinard G, DuBoff E, Halaris A, Kim SW, Koran L, Liebowitz M, Lydiard RB, Rasmussen S, White K. 1995. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatty 52:289-295.
39. Grisham JR, Brown TA, Liverant GI, Campbell-Sills L. 2005. The distinctiveness of compulsive hoarding from obsessive-compulsive disorder. J Anxiety Disord 19:767-779.
40. Grossman LS, Martis B, Fichtner CG. 1999. Are sex offenders treatable? A research overview. Psychiatr Serv 50:349-361.
41. Himle MB, Woods DW, Piacentini JC, Walkup JT. 2006. Brief review of habit reversal training for Tourette syndrome. J Child Neurol 21:719-725.
42. Hodgson R, Rachman S. 1972. The effects of contamination and washing in obsessional patients. Behav Res Ther 10:111-117.
43. Hollander E. 1993. Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann 23:355-358.
44. Hollander E, Evers M. 2004. Review of obsessive-compulsive spectrum disorders: what do we know? Where are we going? Clin Neuropsychiatry 1:32-51.
45. Hollander E, Friedberg JP, Wasserman S. 2005. The case for the OCD spectrum. In: Abramowitz JS, Houts AC, editors. Concepts and controversies in obsessive-compulsive disorder. New York, NY, USA: Springer Science. p 95-118.
46. Hollander E, Kim S, Khanna S, Pallanti S. 2007. Obsessive-compulsive disorder and obsessive-compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr 12:5-13.
47. Hollander E, Zohar J. 2004. Beyond refractory obsessions and anxiety states: toward remission. J Clin Psychiatry 14:3-5.
48. Hyman SE. 2007. Can neuroscience be integrated into the DSM-V? Nat Rev Ncurosci 8:725-732.
49. Jenike M. 2004. Clinical practice. Obsessive-compulsive disorder. N Engl J Med 350:259-265.
50. Kafka MP. 1994. Sertraline pharmacotherapy tor paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 6:189-195.
51. Ladouceur R, Freeston MH, Rheanme J, Dugas MJ, Gagnon F, Thihodeau N, Founder S. 2000. Strategies used with intrusive thoughts: a comparison of OCD patients with anxious and community controls. J Abnorm Psychol 109:179-187.
52. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen AS, Goodman WK, McDougle CJ, Pauls DL. 1997. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 154:911-917.
53. Leckman JF, Grice DE, Barr LC, de Vries ALC, Martin C, Cohen DJ, McDougle CJ, Goodman WK, Rasmussen SA. 1995. Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety 1:208-215.
54. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. 1991. Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48:324-328.
55. Lochner C, Kinnear CJ, Hemmings SM, Seller C, Niehaus DJ, Knowles JA, Daniels W, Moolman-Smook JC, Seedat S, Stein DJ. 2005. Hoarding in obsessive-compulsive disorder: clinical and genetic correlates. J Clin Psychiatry 66:1155-1160.
56. Lochner C, Stein DJ. 2006. Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessive-compulsive disorder? Prog Neuropsychopharmacol Biol Psychiatry 30:353-361.
57. Mataix-Cols D, Pertusa A, Leckman JF. 2007. Issues for DSM-V: how should obsessive-compulsive and related disorders be classified? Am J Psychiatry 164:1313-1314.
58. McElroy SL, Hudson JI, Pope HG, Keck PE. 1991. Kleptomania: clinical characteristics and associated psychopathology. Psychol Med 21:93-108.
59. McElroy SL, Keck Jr PE, Pope Jr HG, Hudson JI. 1989. Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol 9:358-360.
60. Mitchell JE, Burgard M, Faber R, Crosby RD, de Zwaan M. 2006. Cognitive behavioral therapy for compulsive buying disorder. Behav Res Ther 44:1859-1865.
61. Moskowitz JA. 1980. Lithium and lady luck; use of lithium carbonate in compulsive gambling. N Y State J Med 80:785-788.
62. Nakatani E, Nakagawa A, Nakan T, Yoshizato C, Nabeyama M, Kudo A, Isomura K, Kato N, Yoshioka K, Kawamoto M. 2005. A randomized controlled trial of Japanese patients with obsessive-compulsive disorder effectiveness of behavior therapy and fluvoxamine. Psychother Psychosom 74:269-276.
63. Nemeroff CB, Schatzberg AF. 1999. Recognition and treatment of psychiatric disorders: a psychopharmacology handbook for primary care. American Psychiatric Association: Washington, DC.
64. Nestadt G, Samuels J, Riddle MA, Liang KY, Bienvenu OJ, Hoehn-Saric R, Grados M, Cullen B. 2001. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med 31:481-487.
65. Ninan PT, Rothbaum BO, Marsteller FA, Knight BT, Eccard MB. 2000. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry 61:47-50.
66. Noyes Jr R. 1999. The relationship of hypochondriasis to anxiety disorders. Gen Hosp Psychiatry 21:8-17.
67. Obsessive-Compulsive Cognitions Working Group. 2003. Psychometric validation of the Obsessive Beliefs Questionnaire and the Interpretation of Intrusions Inventory: part I. Behav Res Ther 41:863-878.
68. QCCWG. 1997. Cognitive assessment of obsessive-compulsive disorder. Obsessive Compulsive Cognitions Working Group. Behav Res Ther 35:667-681.
69. Phillips KA, Kim JM, Hudson JI. 1995. Body image disturbance in body dysmorphic disorder and eating disorders. Psychiatr Clin North Am 18:317-334.
70. Rachman S. 1997. A cognitive theory of obsessions. Behav Res Ther 35:793-802.
71. Rachman S. 1998. A cognitive theory of obsessions: elaborations. Behav Res Ther 36:385-401.
72. Rachman S, Shafran R. 1998. Cognitive and behavioral features of obsessive-compulsive disorder. In: Swinson RP, Antony MM, Rachman S, Richter MA, editors. Obsessive-compulsive disorder: theory, research, and treatment. New York, NY, USA: Guilford Press. p 51-78.
73. Richter MA, Summerfeldt LJ, Antony MM, Swinson RP. 2003. Obsessive-compulsive spectrum conditions in obsessive-compulsive disorder and ether anxiety disorders. Depress Anxiety 18: 118-127.
74. Roper G, Rachman S. 1976. Obsessional-compulsive checking: experimental replication and development. Behav Res Ther 14:25-32.
75. Roper G, Rachman S, Hodgson R. 1973. An experiment on obsessional checking. Behav Res Ther 11:271-277.
76. Salkovskis PM. 1985. Obsessional-compulsive problems: a cognitive-behavioural analysis. Behav Res Ther 23:571-583.
77. Salkovskis PM. 1989. Obsessions and compulsions. In: Scott J, Williams JM, Beck AT, editors. Cognitive therapy in clinical practice: an illustrative casebook. Florence, KY, USA: Taylor & Francis/Routledge. p 50-77.
78. Savron G, Fava GA, Grandi S, Rafanelli C, Raffi AR, Belluardo P. 1996. Hypochondriacal fears and beliefs in obsessive-compulsive disorder. Acta Psychiatr Scand 93:345-348.
79. Saxena S, Rauch SL. 2000. Functional neuroimaging and the neuroanatomy of obsessive compulsive disorder. Psychiatr Clin North Am 23:563-586.
80. Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF. 1992. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. J Clin Psychiatry 53:267-271.
81. Stein DJ, Liu Y, Shapira NA, Goodman WK. 2001. The psychobiology of obsessive-compulsive disorder: how important is the role of disgust? Curr Psychiatry Rep 3:281-287.
82. Stein DJ, Lochner C. 2006. Obsessive-compulsive spectrum disorders: a multidimensional approach. Psychiatr Clin North Am 29:343-351.
83. Storch EA, Geffken GR, Merlo LJ, Mann G, Duke D, Munson M, Adkins J, Grabill KM, Murphy TK, Goodman WK. 2007. Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 46:469-478.
84. Storch EA, Merlo LJ. 2006. Treatment of the patient with obsessive-compulsive disorder. J Fam Prac 55:329-333.
85. Streichenwein SM, Thornby JI. 1995. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry 152:1192-1196.
86. Summerfeldt L, Hood K, Antony M, Richter M, Swinson R. 2004. Impulsivity in obsessive-compulsive disorder: comparisons with other anxiety disorders and within tic-related subgroups. Pers Individ Differences 36:539-553.
87. Taylor S. 1996. Meta-analysis of cognitive-behavioral treatments for social phobia. J Behav Ther Exp Psychiatry 27:1-9.
88. Tollefson GD, Rampey Jr AH, Potvin JH, Jenike MA, Rush AJ, Kominguez RA, Koran LM, Shear MK, Goodman W, Genduso LA. 1994. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive compulsive disorder. Arch Gen Psychiatry 51:559-567.
89. van den Hout M, van Pol M, Peters M. 2001. On becoming neutral: effects of experimental neutralizing reconsidered. Behav Res Ther 39:1439-1448.
90. Van Minnen A, Hoogduin KA, Keijsers GP, Hellenbrand F, Hendriks GJ. 2003. Treatment of trichotillomania with behavioral therapy or fluoxetine: a randomized, waiting-list controlled study. Arch Gen Psychiatry 60:517-522.
91. Wells A. 2000. Emotional disorders and metacognition: Innovative cognitive therapy. Wells, Adrian; New York, NY, USA: John Wiley & Sons.
92. Whiteside SP, Port JD, Abramowitz JS. 2004. A meta-analysis of functional ncuroimaging in obsessive-compulsive disorder. Psychiatry Res 32:69-79.